Systematix H1 profit fell 67% amid private-wealth build

Systematix Group reported H1 FY27 adjusted operating income of Rs 83.67 crore, down 6% year on year, while profit after tax fell 67% to Rs 8.24 crore as it funded upfront private-wealth platform investment. Q2 adjusted operating income rose 102% sequentially to Rs 55.94 crore, but this did not offset the Q1 loss.

What drove Systematix’s H1 FY27 profit decline?

Systematix’s H1 FY27 decline reflected lower adjusted operating income and a Q1 loss despite a profitable Q2. Adjusted operating income fell from Rs 89.07 crore in H1 FY26 to Rs 83.67 crore, while profit before tax, or PBT, declined 57% from Rs 33.24 crore to Rs 14.11 crore. Profit after tax, or PAT, decreased from Rs 24.94 crore to Rs 8.24 crore.

Reported total income from operations moved in the opposite direction, rising to Rs 114.07 crore in H1 FY27 from Rs 89.07 crore in H1 FY26. Systematix adjusts revenue from share trading to show the net profit or loss earned from that activity, which explains why its adjusted measure fell while the reported total-income line increased.

How did Systematix’s Q2 FY27 compare with Q1 and last year?

Systematix recovered in Q2 FY27 from Q1, although Q2 PBT and PAT remained below the prior-year quarter. Adjusted operating income rose from Rs 27.74 crore in Q1 FY27 to Rs 55.94 crore in Q2 FY27, a 102% sequential increase, and was marginally above Rs 55.72 crore in Q2 FY26. PBT reached Rs 17.18 crore after a Rs 3.08 crore Q1 loss, but was below Rs 19.37 crore a year earlier.

PAT changed from a Rs 4.89 crore loss in Q1 FY27 to a Rs 13.13 crore profit in Q2 FY27, compared with Rs 14.48 crore in Q2 FY26. PAT margin was 29% in Q2 FY27 versus 34% a year earlier. Basic and diluted earnings per share were Rs 0.96 in Q2 FY27, against Rs 1.06 in Q2 FY26 and a loss per share of Rs 0.36 in Q1 FY27.

Why is Systematix investing in private wealth?

Systematix said near-term profitability was affected by upfront investment to scale its private-wealth platform. The presentation identifies senior-talent acquisition, technology enablement and regulatory infrastructure as the three areas of spending. Management said the investment affected short-term profitability and is expected to support sustainable revenue growth.

The presentation does not quantify private-wealth investment separately or give a completion date for the build-out. Its H1 FY27 PBT of Rs 14.11 crore and PAT of Rs 8.24 crore compare with Rs 33.24 crore and Rs 24.94 crore, respectively, in H1 FY26. Systematix also reported Q2 FY27 net worth of Rs 322.46 crore, but did not identify what portion related to private wealth.

Which operating indicators changed in Q2 FY27?

Systematix’s total assets under management, or AUM, rose to Rs 1,151 crore in Q2 FY27 from Rs 910 crore in Q1 FY27. Mutual-fund AUM accounted for most of the increase, rising Rs 200 crore to Rs 803 crore. Portfolio-management-services, or PMS, AUM increased to Rs 223 crore from Rs 188 crore, while alternative-investment-fund, or AIF, AUM rose to Rs 125 crore from Rs 119 crore.

Assets under custody increased to Rs 12,200 crore from Rs 10,800 crore, while team strength rose to 38 from 25 between Q1 and Q2 FY27. Systematix opened four offices across Mumbai, Indore, Kolkata and Delhi, although the presentation does not allocate those offices or additional headcount specifically to private wealth. The PCG desk’s broking clients increased from 73 to 95 and broking AUM rose from Rs 520 crore to Rs 658 crore.

What plans and pipeline has Systematix disclosed?

Systematix disclosed a transaction pipeline valued at more than Rs 12,600 crore across more than 27 active opportunities. The largest stated opportunity was a Rs 3,000 crore capital-goods qualified institutional placement, or QIP. Other disclosed opportunities included Rs 1,375 crore across two fast-moving-consumer-goods initial public offerings, or IPOs, and Rs 1,000 crore across two renewable-energy IPOs.

In asset management, the India Equity Opportunities Fund, an AIF Category II product, had investor interest or commitments of more than Rs 170 crore against a Rs 750 crore to Rs 800 crore fund-raise target. The India SME Growth Fund, an AIF Category I product, had completed seven investments and drawn 65% of capital, with two portfolio companies listed and three having filed draft red herring prospectuses. The Systematix India Select Equity Fund, an AIF Category III product, had received Securities and Exchange Board of India approval.

Conclusion

Systematix’s H1 FY27 figures show that the Q2 recovery did not reverse the effect of the Q1 loss and lower half-year adjusted operating income. Adjusted operating income was Rs 83.67 crore and PAT was Rs 8.24 crore, while management attributed near-term profitability pressure to investment in private-wealth talent, technology and regulatory infrastructure.

The next disclosed markers are execution of the private-wealth platform build and progress toward the Rs 750 crore to Rs 800 crore target for the India Equity Opportunities Fund. Investors can also monitor whether the more than Rs 12,600 crore transaction pipeline converts into completed transactions, as Systematix has not provided a timetable or conversion estimate.